UBS Group AG

SEC CIK: 0001610520
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

ELV holding history

Elevance Health, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELV overview All 13F holders of ELV Full Q2 2026 holdings

Shares (Q2 2026): 739,833
Value: $286.1M
% of portfolio: <0.1%
Quarters held: 22; Since Q1 2021

Holdings of ELV by UBS Group AG, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	739,833	$286.1M	<0.1%	+4,703+0.6%	Added	Holders
Q1 2026	735,130	$215.2M	<0.1%	−76,334−9.4%	Reduced	Holders
Q4 2025	811,464	$284.5M	0.1%	−117,962−12.7%	Reduced	Holders
Q3 2025	929,426	$300.3M	0.1%	+83,508+9.9%	Added	Holders
Q2 2025	845,918	$329.0M	0.1%	−89,488−9.6%	Reduced	Holders
Q1 2025	935,406	$406.9M	0.1%	−170,434−15.4%	Reduced	Holders
Q4 2024	1,105,840	$407.9M	0.1%	+287,400+35.1%	Added	Holders
Q3 2024	818,440	$425.6M	0.1%	+94,992+13.1%	Added	Holders
Q2 2024	723,448	$392.0M	0.1%	−8,871−1.2%	Reduced	Holders
Q1 2024	732,319	$379.7M	0.1%	+143,661+24.4%	Added	Holders
Q4 2023	588,658	$277.6M	0.1%	+90,664+18.2%	Added	Holders
Q3 2023	497,994	$216.8M	0.1%	−159,581−24.3%	Reduced	Holders
Q2 2023	657,575	$292.2M	0.1%	+164,171+33.3%	Added	Holders
Q1 2023	493,404	$226.9M	0.1%	−126,682−20.4%	Reduced	Holders
Q4 2022	620,086	$318.1M	0.2%	+184,409+42.3%	Added	Holders
Q3 2022	435,677	$197.9M	0.1%	−35,186−7.5%	Reduced	Holders
Q2 2022	470,863	$227.2M	0.1%	+71,247+17.8%	Added	Holders
Q1 2022	399,616	$196.3M	0.1%	−6,590−1.6%	Reduced	Holders
Q4 2021	406,206	$188.3M	0.1%	−79,274−16.3%	Reduced	Holders
Q3 2021	485,480	$181.0M	0.1%	+20,711+4.5%	Added	Holders
Q2 2021	464,769	$177.4M	0.1%	−1,326−0.3%	Reduced	Holders
Q1 2021	466,095	$167.3M	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.